Clinical trial
A Prospective Study to See if Cardiac Effects of Herceptin Can be Prevented With Standard Heart Medications
NCT01016886 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Study to See if Cardiac Effects of Herceptin Can be Prevented With Standard Heart Medications
- Lead sponsor
- University of Alberta
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- September 30, 2010
- Completion date
- September 30, 2016
- Enrollment
- 99 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, heart failure